4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: January 23, 2020
Period of Report: December 30, 2019
Accession Number: 0001645470-20-000001

View Document ↗ View on SEC.gov ↗